Frontlight ResearchEarly access
Active, not recruitingNo phase
Geko™ Cross Therapy Registry - Wound
Key facts
- Who runs it
- Firstkind Ltd
- Where
- New York, United StatesSee the siteAlso in 1 other country, 2 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 2,500 people, planned
- Started
- 4 Apr 2022
- Expected to end
- Mar 2028
- Type of study
- Observational
- Treatments tested
- geko device
- Record updated
- 15 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Aged ≥ 18 years
- Intact healthy skin at the site of geko™ device application
- Willing and able to give written informed consent
- Presence of an ulcerative wound to the lower leg
- Identified to receive geko™ therapy as part of their standard care for wound management
Who cannot take part
- No response to geko™ therapy i.e., no involuntary rhythmic upward and outward movement of the foot (dorsiflexion) at the maximum tolerable device setting
- Pregnancy or breast feeding
- Use of any other neuro-modulation device
- Current use of TENS in the pelvic region, back or legs
- Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve
Where in United States
Also in 1 other country, 2 sites
- Northwell Health SystemNew York, United States
About the trial
What the trial wants to find out
The geko™ Cross Therapy REGISTRY - Wound is a prospective, observational, anonymised data collection Registry with no experimental treatment that will fulfil an unmet need for an observational Registry to provide long-term clinical data to demonstrate patient benefit and regulatory compliance.
The group in the trial
- Standard of care
Patients who are receiving the geko device as part of standard of care for wound management
Treatment: geko device
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Geko™ Cross Therapy Registry - Wound An Observational Study for the Post Market Clinical Follow-up of Safety and Patient Outcomes for Patients Undergoing Peroneal Nerve Stimulation by Geko™
- Record updated
- 15 September 2026